SAFE: Founder Friendly or Opportunistic?

A review of the Pros and Cons of this prolific investment vehicle

When meeting with Israeli companies and executives, the term “SAFE” often comes up in discussions about raising capital. Conversations with Israeli investors and venture capital professionals suggest that this structure is widely accepted in the market. By contrast, SAFEs are used less frequently in many traditional U.S. and Canadian private market transactions, which makes it worthwhile to explain how the structure works and where it may benefit or disadvantage investors.

What a SAFE really is, from an investor’s perspective

At its core, a SAFE (Simple Agreement for Future Equity) is a contract: an investor provides capital today in exchange for the right to receive equity later, usually when the company completes a priced financing round or a liquidity event occurs.

The investor does not become a shareholder when the SAFE is signed. Instead, the investor holds a contractual claim that may convert into shares in the future.

Unlike convertible debt, a SAFE usually carries no interest and no maturity date. That means the company is not under pressure to repay the investor on a fixed schedule, and the investor has no built-in deadline to force conversion or repayment. Economically, the investor is taking equity-style risk, with the eventual price per share determined by a valuation cap, a discount to the next round, or both.

For an investor, the practical implication is simple: a SAFE offers exposure to early-stage upside, but with delayed ownership, limited control, and the real possibility that the instrument never converts into meaningful equity.

Why founders prefer SAFEs—and what that means for investors

Founders often use SAFEs because they allow capital to be raised without setting a firm valuation at the outset.

• Valuation is deferred. At the pre-seed or seed stage, when there may be limited revenue and a wide range of possible outcomes, delaying the valuation discussion can accelerate the fundraising process.
• Execution is streamlined. SAFEs are short, standardized documents that can be executed quickly and at relatively low legal cost.
• Balance sheet is cleaner. Unlike convertible notes, SAFEs generally do not accrue interest and do not have maturity dates, which gives the company more flexibility during an early growth period.

That speed can be attractive to investors as well, particularly when backing a company early, but it also means there is less time and often less pressure to negotiate investor protections.

Typical SAFE structure: terms investors should underwrite

• Trigger events: A SAFE generally converts when a defined event occurs, most commonly a priced equity financing such as a Seed or Series A round, and in some cases a liquidity event such as an acquisition.
• Valuation cap: The valuation cap sets the maximum company valuation at which the SAFE will convert into equity.
• Discount: Many SAFEs also include a discount to the next round’s share price, often in the range of 15 to 25 percent.
• Cap versus discount: In many cases, the SAFE converts based on whichever is more favorable to the investor: the valuation cap or the discount formula.
• No interest and no maturity: This simplifies the structure, but it can also leave capital tied up for years if the company never completes a qualifying round.
• Limited rights: Standard SAFEs generally do not provide voting rights, board representation, liquidation preferences, or full shareholder protections.

Red flags and structural risks for investors

• No valuation cap: An uncapped SAFE may leave the investor exposed if the next round is priced aggressively.
• Stacked SAFE rounds: Multiple SAFEs with different caps and discounts can create significant dilution once all instruments convert.
• Ambiguous trigger definitions: Narrow or unusual language around conversion events can produce unexpected outcomes.
• Weak information rights: Without updates, financial reporting, or pro-rata rights, investors may have little visibility into their position.
• Business mismatch: SAFEs work best in companies likely to pursue institutional financing. In businesses that may never complete a priced round, non-conversion risk is higher.

How often SAFEs are used

SAFEs have become a standard fundraising instrument in the early-stage venture ecosystem, especially in technology startups raising pre-seed and seed capital.

They are commonly used in small angel rounds, bridge financings, and some equity crowdfunding offerings where valuation is difficult to establish upfront. They are less common in later-stage financings and in more traditional private market transactions where investors expect direct equity ownership and fuller governance rights.

What investors should know before investing via SAFE

1. Request a cap table model. Ask the company to show ownership after all SAFEs convert at one or more plausible next-round valuations.
2. Understand the conversion mechanics. Review how the cap and discount interact and confirm which formula applies under different scenarios.
3. Assess the likelihood of a qualifying round. If the business is unlikely to raise institutional capital, the SAFE may remain outstanding indefinitely.
4. Review all outstanding convertibles. One SAFE can seem attractive on its own, but multiple SAFEs can create cumulative dilution that changes the economics significantly.
5. Negotiate side rights where appropriate. Information rights and pro-rata rights can materially improve the investor’s position.
6. Consider tax and jurisdictional issues. Local legal and tax treatment can affect the ultimate value of the investment.

Five questions to ask before signing a SAFE

• What valuation cap is being offered, and how does it compare to the likely next-round valuation?
• Does the SAFE include a discount, and if so, how is it applied if there is also a cap?
• How many SAFEs or other convertible instruments are already outstanding?
• What specific events trigger conversion, and what happens if those events never occur?
• Will the investor receive information rights, pro-rata rights, or any other protections before conversion?

Founder friendly or opportunistic?

The answer is that a SAFE can be both.

It is founder-friendly because it speeds fundraising, defers valuation, and removes the debt-like features of notes. But it can also become opportunistic when the structure is used without full transparency around dilution, rights, or the realistic probability of conversion.

For investors, the right question is not whether SAFEs are good or bad in the abstract. The more useful question is whether a specific SAFE, with its particular cap, discount, trigger terms, and investor protections, fits the investor’s strategy and risk tolerance.